| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $203.7M | $46.2M | $341.5M |
| YoY Revenue Growth % | +340.9% | -86.5% | — |
| Gross Profit | $48.0M | $6.2M | — |
| Gross Margin % | 23.6% | 13.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$74.4M | -$130.0M | -$106.7M |
| Operating Margin % | -36.5% | -80.0% | -31.3% |
| Net Income (GAAP) | -$103.6M | -$135.8M | -$98.4M |
| EBITDA (Normalized) | -$41.5M | -$82.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.6M | -$55.9M | -$92.7M |
| Capital Expenditures (CapEx) | $41.1M | $58.9M | — |
| Free Cash Flow (FCF) | -$46.7M | -$114.7M | -$92.7M |
| FCF Margin % | -22.9% | -80.0% | -27.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $58.3M | $27.1M | — |
| Total Debt (Short + Long Term) | $38.0M | $0 | — |
| Total Stockholders' Equity | $88.6M | $126.3M | — |